Athena Global Technologies Limited has scheduled a board meeting for February 14, 2026, to review its third quarter financial performance and consider strategic fund raising initiatives. The meeting will be held at the company's registered office in Hyderabad.

Board Meeting Agenda

The board of directors will convene to address two primary matters during the scheduled meeting. The agenda includes a comprehensive review of the company's financial performance and strategic funding considerations.

Fund Raising Proposal

The board will deliberate on a fund raising proposal involving the issuance of securities, including warrants that are convertible into equity shares. This initiative will be conducted on a preferential basis, adhering to the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws. The proposal remains subject to necessary approvals, including shareholder consent and statutory/regulatory authority clearances.

Trading Window Restrictions

The company has maintained trading window restrictions for designated persons and their immediate relatives. The trading window, which closed on January 01, 2026, will remain suspended until February 16, 2026. This measure ensures compliance with insider trading regulations during the financial results announcement period.

Regulatory Compliance

The board meeting notification has been issued in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has communicated this information to BSE Limited, where its shares are listed under scrip code 517429. The formal notification was signed by Gayathri Prithviraj, Company Secretary & Compliance Officer, on February 11, 2026.

Athena Global Technologies Limited has announced its financial results for the first quarter ended June 30, along with significant corporate actions. The company's Board of Directors approved both standalone and consolidated unaudited financial results at a meeting held on August 11.

Financial Performance

The company's consolidated results include its subsidiaries Medley Medical Solutions Private Limited, Tutoroot Technologies Private Limited, and Athena Inc. The performance of these subsidiaries for the quarter was as follows:

Warrant Conversion

In a significant move, Athena Global Technologies has converted 6,50,000 share warrants into equity shares. These warrants were originally allotted to Mr. Karthikeya Manchala on February 12, 2024. The conversion price was set at ₹87 per share, which includes a premium of ₹77 over the face value of ₹10 per share.

Fund Utilization

The company had previously raised ₹5.65 crore through a preferential issue of share warrants. As of June 30, Athena Global Technologies has received ₹1.41 crore as an upfront payment, representing 25% of the total warrant amount. The funds are allocated for various purposes including:

1. Long-term capital requirements for future growth
2. Working capital needs
3. Debt reduction
4. General corporate purposes

Regulatory Compliance

The company has submitted its financial results in compliance with Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Independent auditors have reviewed both the standalone and consolidated financial results, finding no material misstatements or deviations from accounting standards.

Athena Global Technologies continues to focus on its growth strategy, utilizing the funds raised to strengthen its financial position and support its operational needs. The conversion of warrants into equity shares demonstrates investor confidence in the company's future prospects.